Watch the Social New Venture (SNVC) Finals today at 9:15am - 4pm CT!
Click here to watch

How Five UChicago Innovators Are Fighting the IP Gender Gap

It is estimated that only 16.2% of inventors named in international patent applications were women in 2022, according to data from the World Intellectual Property Organization (WIPO). In an analysis…

Four Startups Advance to Spring 2023 George Shultz Innovation Fund Finals

Four startups innovating in the life sciences, energy, healthcare IT, and medical device spaces will each vie for up to $250,000 in co-investment as finalists in the Spring 2023 cohort…

2 Startups Awarded $175,000 Each to Further Develop Cancer Treatment Technologies

Alnair Therapeutics and Riptide Therapeutics have been awarded investments from the George Shultz Innovation Fund to further develop their cancer treatment technologies. Both will receive $175,000 investments from the Fund.…

Riptide Therapeutics Awarded $175,000 From George Shultz Innovation Fund

The George Shultz Innovation Fund (GSIF), managed by the Polsky Center for Entrepreneurship and Innovation, recently selected Riptide Therapeutics, a biopharmaceutical startup led by University of Chicago and Northwestern University…

Alnair Therapeutics Awarded $175,000 From George Shultz Innovation Fund

The George Shultz Innovation Fund (GSIF), managed by the Polsky Center for Entrepreneurship and Innovation, recently selected oncology startup Alnair Therapeutics as a Fall 2022 cohort award winner. The company,…

UChicago, Duality Teams to Pitch at 2021 Chicago Venture Summit

Several teams from the University of Chicago and Duality – the world’s first accelerator focused exclusively on quantum technologies – pitched at the 2021 Chicago Venture Summit. The venture…

Esya Labs and HeioThera Receive $250,000 Investment from the George Shultz Innovation Fund

The 2021 Spring Cohort of the George Shultz Innovation Fund has invested $250,000 in both Esya Labs and HeioThera – and this number will increase as they solidify additional funding.…

Esya Labs Supports Drug Discovery Efforts at Novartis: ‘This is Only the Beginning,’ says CEO

Esya Labs, which is developing several ground-breaking novel research assays, today has announced that Novartis is among the first companies to use its technology. Novartis, a global healthcare company, has…

Polsky Launches DeepTechU to Connect Investors with Faculty Startups in Deep Tech

The University of Chicago’s Polsky Center for Entrepreneurship and Innovation is launching DeepTechU, a venture conference convening investors and faculty innovators to showcase deep tech innovation. “Our faculty at…

Esya Labs Leads Paradigm Shift in Alzheimer’s Using Novel Biomarkers and AI for Revolutionary 360° Perspective of Disease

Esya Labs is developing tools for the early, precise, and cost-effective detection of neurodegenerative diseases to support drug discovery and personalized medicine efforts. In her lab at the University…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept